Entry |
|
Symbol |
ADCY5
|
Name |
|
Pathway |
map04072 | Phospholipase D signaling pathway |
map04213 | Longevity regulating pathway - multiple species |
map04261 | Adrenergic signaling in cardiomyocytes |
map04270 | Vascular smooth muscle contraction |
map04723 | Retrograde endocannabinoid signaling |
map04750 | Inflammatory mediator regulation of TRP channels |
map04914 | Progesterone-mediated oocyte maturation |
map04923 | Regulation of lipolysis in adipocytes |
map04925 | Aldosterone synthesis and secretion |
map04927 | Cortisol synthesis and secretion |
map04928 | Parathyroid hormone synthesis, secretion and action |
map04935 | Growth hormone synthesis, secretion and action |
map05163 | Human cytomegalovirus infection |
map05166 | Human T-cell leukemia virus 1 infection |
map05207 | Chemical carcinogenesis - receptor activation |
|
Reaction |
R00089 | ATP diphosphate-lyase (cyclizing; 3',5'-cyclic-AMP-forming) |
R00434 | GTP diphosphate-lyase (cyclizing; 3',5'-cyclic-GMP-forming) |
|
Disease |
H02389 | Familial dyskinesia with facial myokymia |
H02397 | Neurodevelopmental disorder with movement abnormalities or hypotonia |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09100 Metabolism
09104 Nucleotide metabolism
00230 Purine metabolism
K08045 ADCY5; adenylate cyclase 5
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
K08045 ADCY5; adenylate cyclase 5
04371 Apelin signaling pathway
K08045 ADCY5; adenylate cyclase 5
04072 Phospholipase D signaling pathway
K08045 ADCY5; adenylate cyclase 5
04024 cAMP signaling pathway
K08045 ADCY5; adenylate cyclase 5
04022 cGMP-PKG signaling pathway
K08045 ADCY5; adenylate cyclase 5
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
K08045 ADCY5; adenylate cyclase 5
09144 Cellular community - eukaryotes
04540 Gap junction
K08045 ADCY5; adenylate cyclase 5
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
K08045 ADCY5; adenylate cyclase 5
04062 Chemokine signaling pathway
K08045 ADCY5; adenylate cyclase 5
09152 Endocrine system
04911 Insulin secretion
K08045 ADCY5; adenylate cyclase 5
04923 Regulation of lipolysis in adipocytes
K08045 ADCY5; adenylate cyclase 5
04912 GnRH signaling pathway
K08045 ADCY5; adenylate cyclase 5
04913 Ovarian steroidogenesis
K08045 ADCY5; adenylate cyclase 5
04915 Estrogen signaling pathway
K08045 ADCY5; adenylate cyclase 5
04914 Progesterone-mediated oocyte maturation
K08045 ADCY5; adenylate cyclase 5
04921 Oxytocin signaling pathway
K08045 ADCY5; adenylate cyclase 5
04926 Relaxin signaling pathway
K08045 ADCY5; adenylate cyclase 5
04935 Growth hormone synthesis, secretion and action
K08045 ADCY5; adenylate cyclase 5
04918 Thyroid hormone synthesis
K08045 ADCY5; adenylate cyclase 5
04928 Parathyroid hormone synthesis, secretion and action
K08045 ADCY5; adenylate cyclase 5
04916 Melanogenesis
K08045 ADCY5; adenylate cyclase 5
04924 Renin secretion
K08045 ADCY5; adenylate cyclase 5
04925 Aldosterone synthesis and secretion
K08045 ADCY5; adenylate cyclase 5
04927 Cortisol synthesis and secretion
K08045 ADCY5; adenylate cyclase 5
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
K08045 ADCY5; adenylate cyclase 5
04270 Vascular smooth muscle contraction
K08045 ADCY5; adenylate cyclase 5
09154 Digestive system
04970 Salivary secretion
K08045 ADCY5; adenylate cyclase 5
04971 Gastric acid secretion
K08045 ADCY5; adenylate cyclase 5
04972 Pancreatic secretion
K08045 ADCY5; adenylate cyclase 5
04976 Bile secretion
K08045 ADCY5; adenylate cyclase 5
09156 Nervous system
04724 Glutamatergic synapse
K08045 ADCY5; adenylate cyclase 5
04727 GABAergic synapse
K08045 ADCY5; adenylate cyclase 5
04725 Cholinergic synapse
K08045 ADCY5; adenylate cyclase 5
04728 Dopaminergic synapse
K08045 ADCY5; adenylate cyclase 5
04726 Serotonergic synapse
K08045 ADCY5; adenylate cyclase 5
04723 Retrograde endocannabinoid signaling
K08045 ADCY5; adenylate cyclase 5
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
K08045 ADCY5; adenylate cyclase 5
09149 Aging
04211 Longevity regulating pathway
K08045 ADCY5; adenylate cyclase 5
04213 Longevity regulating pathway - multiple species
K08045 ADCY5; adenylate cyclase 5
09159 Environmental adaptation
04713 Circadian entrainment
K08045 ADCY5; adenylate cyclase 5
04714 Thermogenesis
K08045 ADCY5; adenylate cyclase 5
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
K08045 ADCY5; adenylate cyclase 5
05207 Chemical carcinogenesis - receptor activation
K08045 ADCY5; adenylate cyclase 5
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
K08045 ADCY5; adenylate cyclase 5
05163 Human cytomegalovirus infection
K08045 ADCY5; adenylate cyclase 5
09164 Neurodegenerative disease
05012 Parkinson disease
K08045 ADCY5; adenylate cyclase 5
09165 Substance dependence
05030 Cocaine addiction
K08045 ADCY5; adenylate cyclase 5
05031 Amphetamine addiction
K08045 ADCY5; adenylate cyclase 5
05032 Morphine addiction
K08045 ADCY5; adenylate cyclase 5
05034 Alcoholism
K08045 ADCY5; adenylate cyclase 5
09166 Cardiovascular disease
05414 Dilated cardiomyopathy
K08045 ADCY5; adenylate cyclase 5
09167 Endocrine and metabolic disease
04934 Cushing syndrome
K08045 ADCY5; adenylate cyclase 5
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
K08045 ADCY5; adenylate cyclase 5
Enzymes [BR:ko01000]
4. Lyases
4.6 Phosphorus-oxygen lyases
4.6.1 Phosphorus-oxygen lyases (only sub-subclass identified to date)
4.6.1.1 adenylate cyclase
K08045 ADCY5; adenylate cyclase 5
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Ludwig MG, Seuwen K |
Title |
Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms. |
Journal |
|
Sequence |
|
Reference |
|
Authors |
Ding Q, Gros R, Gray ID, Taussig R, Ferguson SS, Feldman RD |
Title |
Raf kinase activation of adenylyl cyclases: isoform-selective regulation. |
Journal |
|
LinkDB |
|